EP4295836A1 — Sachet comprising a liquid suspension of a sevelamer salt
Assigned to Labomed Pharmaceutical Company SA · Expires 2023-12-27 · 2y expired
What this patent protects
A sealed sachet comprising a liquid pharmaceutical suspension composition of a pharmaceutically acceptable salt of sevelamer suitable for oral administration, wherein the inner layer of the sachet is made of a plastic material consisting essentially of a synthetic organic polymer…
USPTO Abstract
A sealed sachet comprising a liquid pharmaceutical suspension composition of a pharmaceutically acceptable salt of sevelamer suitable for oral administration, wherein the inner layer of the sachet is made of a plastic material consisting essentially of a synthetic organic polymer.
Drugs covered by this patent
- Renvela (SEVELAMER CARBONATE) · Sanofi
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.